delayed-release capsule approved for treating relapsing forms of multiple sclerosis
Fumarox (Dimethyl Fumarate) is a delayed-release capsule approved for treating relapsing forms of multiple sclerosis (ms), including: It reduces relapse rates and slows disease progression with neuroprotective effects. Dosage and Administration: Cbc (lymphocyte count) and liver enzymes must be checked before and during therapy.
Key Benefits:
• Clinically isolated syndrome
• Relapsing-remitting MS (RRMS)
• Active secondary progressive MS It reduces relapse rates and slows disease progression with neuroprotective effects
• Decreases relapse rate
• Slows MS progression